Word

INDIVUTEST

Status

Dead

Status Code

606

Status Date

Monday, December 18, 2023

Serial Number

88651520

Mark Type

4000

Filing Date

Friday, October 11, 2019

Published for Opposition

Tuesday, September 22, 2020

Abandoned Date

Monday, December 18, 2023

Trademark Owner History

IndivuTest GmbH - Owner At Publication

Classifications

9 Scientific apparatus and instruments, namely, tissue punches, punch biopsy, biopsy needles, apparatus for collecting biological samples such as tissue, cuts, blood, serum, plasma, ascites, cerebrospinal fluid, urine or stool; electronic apparatus and instruments for scientific laboratory research, namely, electronic analyzers and analyzers for the qualitative and quantitative recognition of samples and identification of the sample type; scientific electronic apparatus for the typing of tissue and tissue samples and tissue cuts; apparatus for recording, transmission or reproduction of data, magnetic data carriers, data processing equipment and computers

5 Pharmaceutical and veterinary preparations, in particular medicines for human beings and animals, namely, pharmaceutical and veterinary preparations for the treatment of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; human and animal sample material, namely, allograft or xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool; test kits for human and animal sample material, namely, allograft or xenograft tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool; diagnostic and therapeutic preparations, in particular made by using molecular biological, molecular genetic, genetic engineering, immunological and biotechnical methods for clinical and medical and laboratory use

44 Medical analyses in connection with the treatment of individuals including X-rays and blood samples, namely, medical testing for diagnostic and treatment purposes; medical clinic services; pharmaceutical advisory services; medical diagnostic testing, monitoring and reporting services

42 Scientific research; design and development of new technology for others in the field of cancer, metabolic diseases, cardiovascular diseases, inflammatory diseases, diseases of the immune system; industrial analysis and research services; design and development of computer hardware and software, in particular computer programs; scientific research for medical purposes, in particular molecular biological, immunological and histological laboratory services, in particular research and development in the field of human medical and veterinary medical diagnostics and therapy; scientific research for medical purposes and in the field of genetic engineering in the nature of typing of tissue and tissue samples and cuts by means of molecular biological, immunological, and histological methods; diagnostic services in the medical field for scientific research services purposes; diagnostic services in the field of cancer for scientific research services purposes; diagnostic services for scientific research services purposes related to the generation of complex data and data sets obtained by multi-omics analysis of human and animal samples, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool, and provision of such data and data sets in whole or in part, unprocessed or processed, to patients, scientists, physicians, medical institutions or scientific institutions; generation of complex data and data sets by multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool; diagnostic services related to generated and/or analysed complex data and data sets received through multi-omics analysis of human and animal sample material, namely, tissue samples, tissue preparations, tissue cuts, blood plasma, blood serum, ascites, cerebrospinal fluid, human and animal urine and human and animal stool

Trademark Events

Dec 18, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Dec 18, 2023

Abandonment - No Use Statement Filed

Apr 28, 2023

Notice Of Approval Of Extension Request E-Mailed

Apr 27, 2023

Sou Extension 5 Granted

Apr 21, 2023

Sou Extension 5 Filed

Apr 27, 2023

Case Assigned To Intent To Use Paralegal

Apr 21, 2023

Sou Teas Extension Received

Nov 16, 2022

Notice Of Approval Of Extension Request E-Mailed

Nov 14, 2022

Sou Extension 4 Granted

Nov 14, 2022

Sou Extension 4 Filed

Nov 14, 2022

Sou Teas Extension Received

May 13, 2022

Notice Of Approval Of Extension Request E-Mailed

May 11, 2022

Sou Extension 3 Granted

May 11, 2022

Sou Extension 3 Filed

May 11, 2022

Sou Teas Extension Received

Nov 2, 2021

Notice Of Approval Of Extension Request E-Mailed

Oct 29, 2021

Sou Extension 2 Granted

Oct 29, 2021

Sou Extension 2 Filed

Oct 29, 2021

Sou Teas Extension Received

May 8, 2021

Notice Of Approval Of Extension Request E-Mailed

May 6, 2021

Sou Extension 1 Granted

May 6, 2021

Sou Extension 1 Filed

May 6, 2021

Sou Teas Extension Received

Nov 17, 2020

Noa E-Mailed - Sou Required From Applicant

Sep 22, 2020

Official Gazette Publication Confirmation E-Mailed

Sep 22, 2020

Published For Opposition

Sep 2, 2020

Notification Of Notice Of Publication E-Mailed

Aug 19, 2020

Approved For Pub - Principal Register

Aug 4, 2020

Teas/Email Correspondence Entered

Aug 3, 2020

Correspondence Received In Law Office

Aug 3, 2020

Teas Response To Office Action Received

Feb 18, 2020

Notification Of Non-Final Action E-Mailed

Feb 18, 2020

Non-Final Action E-Mailed

Feb 18, 2020

Non-Final Action Written

Feb 3, 2020

Previous Allowance Count Withdrawn

Jan 28, 2020

Withdrawn From Pub - Og Review Query

Jan 16, 2020

Approved For Pub - Principal Register

Jan 16, 2020

Assigned To Examiner

Oct 17, 2019

New Application Office Supplied Data Entered

Oct 15, 2019

New Application Entered